GHK-CU

Where GHK-Cu Came From and What It Is Found by Accident, in Blood In 1973 Loren Pickart was comparing blood plasma from young and old donors. He put liver cells from older patients into plasma from younger ones, and the old cells started behaving like young ones. Something in the young plasma was doing it. He tracked it down to a three-residue peptide bound to albumin: glycyl-histidyl-lysine. That is GHK, and the copper came next. The Copper Part GHK binds copper(II) tightly, and the complex is what most research uses. The histidine residue does the holding. Copper is an essential trace element and a cofactor for several enzymes, including lysyl oxidase, which cross-links collagen and elastin fibres. That connection between a copper-carrying peptide and the enzymes that build connective tissue is why the molecule attracted attention in the first place. It Declines With Age Plasma levels of GHK are roughly 200 nanograms per millilitre at age 20 and roughly 80 by age 60. That measured decline is the single most cited fact about the compound and the reason it turns up in ageing research. It is an observation about concentration in blood. What follows from it is a question rather than an answer. Topical Versus Everything Else GHK-Cu has a genuine regulatory identity in cosmetics. Under the name Copper Tripeptide-1 it has been a skincare ingredient for decades, and controlled facial studies exist. Those studies are small and short, and reviewers say so. More importantly, they test a topical cream on skin. No regulator has approved GHK-Cu in any injectable form, and topical results do not transfer to any other route.

We specialize in supplying high-purity research peptides with a focus on transparency, fast domestic delivery, and dedicated customer support.

GHK-Cu has one of the larger research literatures of any compound in our catalogue, and also one of the more lopsided ones.

The cell-culture work is extensive. Studies report changes in expression across a wide set of genes, effects on collagen and glycosaminoglycan synthesis in fibroblast cultures, and activity in various wound models. Much of this sits behind the compound’s reputation.

The human work is almost entirely topical and cosmetic. Controlled facial studies of creams containing the peptide have reported measurable changes, and reviewers consistently note the same limitations: small numbers of participants and short study periods.

What does not exist is a body of controlled human work on GHK-Cu given any other way. The cosmetic literature and the cell-culture literature are both real; neither tells you what happens outside those settings.

That is an unusual position for a research compound, which is well studied in two narrow contexts, unstudied in most others, and it is worth understanding before reading any claim made about it.

Have questions about GHK-Cu products or research-use details? Our team can help you review available options, product information, storage guidance, and ordering details.

A well-characterised copper peptide with a documented history, published specifications and local stock.

We supply high-purity GHK-Cu and other research peptides with consistent quality, transparent pricing, and reliable local delivery. Every order ships from inside Costa Rica — no customs delays, no import duties.